Article
Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc.
British journal of cancer - 9 Sept 2002
Roccato E, Miranda C, Ranzi V, Gishizki M, Pierotti M A, Greco A
Abstract excerpt
The thyroid TRK-T3 oncogene, produced by a chromosomal translocation, is a chimeric, constitutively activated version of the NTRK1/NGF receptor and it is able to transform NIH3T3 cells and differentiate PC12 cells. TRK-T3 oncoprotein triggers multiple signal transduction pathways. Among others, TRK-T3 binds and phosphorylates the Shc and SNT1/FRS2 adaptor proteins both involved in coupling the receptor tyrosine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
